The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0284-2015·Announced 2014-12-03

Hospira Recalls Normosol-R IV Bags Due to Sterility Concerns

Hospira is recalling 305,664 bags of Normosol-R Multiple Electrolytes Injection due to potential punctures that may compromise sterility and cause leaks.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an intravenous product, which carries a significant risk of serious injury or infection.

Plain-English summary

Hospira Inc. is recalling 305,664 bags of Normosol-R Multiple Electrolytes Injection Type 1, USP, 1000 mL container. The affected product is identified by NDC 0409-7967-09 and includes Lot # 32-081-JT (Exp. 08/15) and Lot # 34-115-JT (Exp. 10/15). The product was distributed nationwide, as well as in Puerto Rico and the U.S. Virgin Islands.

The recall was initiated due to a lack of assurance of sterility. The source text indicates a potential for punctures through the overwrap and primary container, which may result in IV bag leaks. This defect could compromise the sterile integrity of the injection.

Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be removed from use and returned to the supplier or the manufacturer as directed by Hospira Inc.

The recalled product

Product
Normosol-R Multiple Electrolytes Injection Type 1, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7967-09.
Manufacturer
Hospira Inc.
Category
Drug — IV Fluids
Hazard
Affected units
305,664

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot # 32-081-JT
  • Exp. 08/15 Lot # 34-115-JT
  • Exp. 10/15

Distribution

Distributed nationwide across the United States.

The notice also names 2 states specifically:

Part of a larger recall action

This product is one of 11 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →

Related recalls

Same manufacturer · Hospira Inc.

See all →

Same hazard · sterility

See all →

Similar recalls